# TADALAFIL
> **ANDA217606** · Abbreviated New Drug Application (Generic) · Sponsor: FOURRTS LABS · Approved 2024-08-13
## Drug
- **FDA Application Number:** ANDA217606
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TADALAFIL
- **Generic name:** TADALAFIL
- **Active ingredients:** TADALAFIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** FOURRTS LABS
- **Manufacturer:** FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED
- **First approval:** 2024-08-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217606)
---
*AI Analytics · CC0 1.0*